Literature DB >> 22476574

Retinal detachment after phakic intraocular lens implantation in severe myopic eyes.

Tingting Jiang1, Qing Chang, Xiaoying Wang, Xin Huang.   

Abstract

BACKGROUND: To report the incidence, clinical presentation, and surgical outcomes of retinal detachment in highly myopic patients corrected by implantation of phakic intraocular lenses (PIOLs).
METHODS: This is a retrospective interventional non-comparative case series. A total of 530 highly myopic eyes that underwent PIOLs implantation were included in the study. All patients completed at least a 2-year follow-up after PIOL implantation. The incidence of retinal detachment (RD) and subsequent treatments were reviewed. The refractive errors, axial lengths, time between refractive surgery and RD detection, vitreoretinal findings, rate of retinal reattachment, and the pre- and postoperative best-corrected visual acuity (BCVA) were analyzed.
RESULTS: The overall incidence of RD was 1.5 % (eight eyes of seven patients) with a mean time between PIOL implantation and detachment of 23.63 ± 18.12 months (range, 2 days-51 months). Mean spherical equivalent (SE) before PIOL implantation was -17.53 ± 3.86 diopters (D) (range, -11.5D to -23.5D). Six patients underwent bilateral PIOL implantation. Five eyes were implanted with anterior chamber PIOLs and the other three received posterior chamber PIOLs. A traumatic history was presented before RD detection in four cases. Horseshoe tears, atrophic holes, or giant retinal tears were found in four (50 %), two (25 %), and two (25 %) eyes, respectively. Two eyes (25 %) underwent scleral buckling surgery, five eyes (62.5 %) underwent pars plana vitrectomy surgery, and one eye (12.5 %) underwent both procedures. Anatomical retinal attachment was achieved after first RD surgery in seven eyes. Mean BCVA after PIOL implantation and before RD was 20/40 (decimal refraction, 0.51 ± 0.31) compared to that of 20/80 (decimal refraction, 0.26 ± 0.12) after the RD surgery. Mean follow-up after RD surgery was 20.63 ± 12.93 months (range, 8-42 months).
CONCLUSIONS: The incidence of RD after PIOLs implantation is low. Its characteristics do not differ significantly from the natural history of RD in high myopic eyes. PIOL implantation for surgical correction of severe myopia does not seem to increase the risk of RD. Good visual prognosis can be obtained with early surgical intervention.

Entities:  

Mesh:

Year:  2012        PMID: 22476574     DOI: 10.1007/s00417-012-2002-z

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  17 in total

1.  Two cases of giant retinal tear after implantation of a phakic intraocular lens.

Authors:  Stanislao Rizzo; Claudia Belting; Federica Genovesi-Ebert
Journal:  Retina       Date:  2003-06       Impact factor: 4.256

Review 2.  Phakic anterior chamber intraocular lenses.

Authors:  G Baikoff
Journal:  Int Ophthalmol Clin       Date:  1991

3.  Safety of posterior chamber phakic intraocular lenses for the correction of high myopia: anterior segment changes after posterior chamber phakic intraocular lens implantation.

Authors:  I Jiménez-Alfaro; J M Benítez del Castillo; J García-Feijoó; J G Gil de Bernabé; J M Serrano de La Iglesia
Journal:  Ophthalmology       Date:  2001-01       Impact factor: 12.079

4.  Rhegmatogenous retinal detachment in phakic eyes after posterior chamber phakic intraocular lens implantation for severe myopia.

Authors:  Vicente Martínez-Castillo; Anna Boixadera; Alicia Verdugo; Daniel Elíes; Andrés Coret; José García-Arumí
Journal:  Ophthalmology       Date:  2005-04       Impact factor: 12.079

5.  Pigmentary dispersion syndrome induced by a posterior chamber phakic refractive lens.

Authors:  J D Brandt; M E Mockovak; A Chayet
Journal:  Am J Ophthalmol       Date:  2001-02       Impact factor: 5.258

6.  Phakic posterior chamber lenses for high myopia: functional and anatomical outcomes.

Authors:  J L Arne; L C Lesueur
Journal:  J Cataract Refract Surg       Date:  2000-03       Impact factor: 3.351

7.  Nuclear sclerotic cataract after vitrectomy in patients younger than 50 years of age.

Authors:  N S Melberg; M A Thomas
Journal:  Ophthalmology       Date:  1995-10       Impact factor: 12.079

8.  U.S. Food and Drug Administration clinical trial of the Implantable Contact Lens for moderate to high myopia.

Authors:  Donald R Sanders; John A Vukich; Kimberley Doney; Monica Gaston
Journal:  Ophthalmology       Date:  2003-02       Impact factor: 12.079

9.  Ultrasound biomicroscopy of silicone posterior chamber phakic intraocular lens for myopia.

Authors:  Julián García-Feijoó; José L Hernández-Matamoros; Carmen Méndez-Hernández; Alfredo Castillo-Gómez; Carlos Lázaro; Teresa Martín; Ricardo Cuiña-Sardiña; Julián García-Sánchez
Journal:  J Cataract Refract Surg       Date:  2003-10       Impact factor: 3.351

10.  Retinal detachment in myopic eyes after phakic intraocular lens implantation.

Authors:  José Maria Ruiz-Moreno; Javier A Montero; Concepción de la Vega; Jorge L Alió; Pedro Zapater
Journal:  J Refract Surg       Date:  2006-03       Impact factor: 3.573

View more
  4 in total

1.  Macular hole following phakic intraocular lens implantation: A case report.

Authors:  Xue-Jing Li; Jia-Liang Duan; Jing-Xue Ma; Qing-Li Shang
Journal:  World J Clin Cases       Date:  2022-07-16       Impact factor: 1.534

2.  Myopic Correction with Iris-Fixated Phakic Intraocular Lenses: Twelve-Year Results.

Authors:  Iveta Nemcova; Jiri Pasta; Katerina Hladikova; Martin Komarc; Darina Pospisilova; Pavel Nemec; Jan Tesar; Vladimir Kratky; Martin Sin
Journal:  J Ophthalmol       Date:  2021-10-07       Impact factor: 1.909

3.  A Comparison of Two Foldable Phakic Intraocular Lenses Implanted in Different Anatomical Compartments: Artiflex Versus Eyecryl.

Authors:  Bulent Kose; Alper Agca
Journal:  Beyoglu Eye J       Date:  2021-09-27

4.  Macular hole following phakic intraocular lens implantation and its management.

Authors:  Atul Kumar; Srikanta K Padhy; Rebika Dhiman; Prashant Kumar; Twinkle Parekh; Toshit Varshney
Journal:  Indian J Ophthalmol       Date:  2019-10       Impact factor: 1.848

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.